20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T83710 | Gastric Inhibitory Peptide (22-51) (human) TFA | GIP (22-51),Glucose-dependent Insulinotropic Peptide (22-51) | |
Gastric inhibitory peptide (GIP) (22-51), a pro-atherogenic peptide comprised of 30 amino acids from the residues 22-51 of its precursor protein proGIP, is present in human plasma. It activates the degradation of IκB-α a... | |||
T83694 | Gastric Inhibitory Peptide (1-42) (porcine) TFA | GIP (1-42),Glucose-dependent Insulinotropic Polypeptide (1-42) | |
Gastric inhibitory peptide (GIP) (1-42), an endogenous incretin hormone comprising 42 amino acids, promotes insulin secretion. Expressed in the intestinal neuroendocrine K cells and submandibular gland, it enters circula... | |||
T83696 | Gastric Inhibitory Peptide 1 (3-42) (human) TFA | Glucose-dependent Insulinotropic Polypeptide 3-42,GIP-1 (3-42) | |
Gastric inhibitory peptide 1 (GIP-1) (3-42), a fragment of the incretin hormone GIP and antagonist to the GIP receptor, is generated through the action of serum dipeptidyl peptidase 4 (DDP-4). When administered at 25 nmo... | |||
T6587 | Mitiglinide Calcium | KAD-1229,S21403 | ATPase , Potassium Channel |
Mitiglinide Calcium (KAD-1229) is a blood glucose-lowering drugs, stimulating insulin secretion by closing the ATP-sensitive K+ channels in pancreatic beta-cells. | |||
T1530 | Mitiglinide calcium hydrate | KAD-1229 calcium hydrate,Mitiglinide calcium,S-21403 calcium hydrate | Potassium Channel |
Mitiglinide calcium hydrate (S-21403 calcium hydrate) is a drug for the treatment of type 2 diabetes. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) K(ATP) channels in pancreatic ... | |||
T83972 | NOX-6-18 | GPR132 antagonist 1,GPR132-B-160 | GPR |
NOX-6-18 (GPR132-B-160) is a highly potent and selective GPR132 antagonist with insulinotropic activity that modulates macrophage reprogramming in pancreatic islets and reduces weight gain. | |||
T7448 | 4-Hydroxyisoleucine | 4-Hydroxy-L-isoleucine | Others |
4-Hydroxyisoleucine (4-Hydroxy-L-isoleucine) has antidepressant-like, antidyslipidemic, and antihyperglycemic effects. It displays an insulinotropic activity. | |||
T37588L | GIP (1-30) amide, porcine acetate | IGF-1R | |
GIP (1-30) amide, porcine acetate is an agonist of fully glucose-dependent insulinotropic polypeptide (GIP) receptor. GIP (1-30) amide, porcine acetate can weakly inhibit gastric acid secretion and strongly stimulate ins... | |||
TP2252 | GLP-1 (9-36) amide | Glucagon Receptor | |
antagonist at the human GLP-1 receptor | |||
T76279 | Retatrutide | LY3437943 | Glucagon Receptor |
Retatrutide (LY3437943) is a triple agonist of the glucagon receptor, glucose-dependent insulinotropic polypeptide receptor, and glucagon-like peptide-1 receptor (GLP-1R), and inhibits GCGR, GIPR, and GLP-1R.Retatrutide ... | |||
T2P2919 | (2S,3R,4S)-4-Hydroxyisoleucine | (4S)-4-Hydroxy-L-isoleucine,Hydroxyisoleucine | PI3K |
(2S,3R,4S)-4-Hydroxyisoleucine (Hydroxyisoleucine) from fenugreek (Trigonella foenum-graecum) seeds is a potential insulinotropic (anti-diabetic) and anti-obesity amino acid. HIL stimulates glucose-dependent insulin secr... | |||
TP1566 | GIP (1-30) amide (Human) (TFA) | ||
GIP (1-30) amide (Human) TFA is a glucose-dependent insulinotropic polypeptide fragment. Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone that stimulates insulin secretion and reduces postprandia... | |||
T37588 | GIP (1-30) amide, porcine | ||
This GIP fragment has potent insulinotropic activity in the isolated, perfused rat pancreas but greatly reduced somatostatinotropic activity in the isolated perfused rat stomach. The site responsible for insulinotropic a... | |||
TP1110 | Tirzepatide hydrochloride | LY3298176 hydrochloride | |
Tirzepatide hydrochloride (LY3298176 hydrochloride) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. | |||
T82316 | GIP, rat TFA | ||
GIP, rat TFA (glucose-dependent insulinotropic polypeptide), a 42-amino acid peptide secreted by K cells in the duodenum and jejunum, promotes insulin release from pancreatic beta cells, supports beta cell proliferation,... | |||
T76310 | Acetyl Gastric Inhibitory Peptide (human) | ||
Acetyl Gastric Inhibitory Peptide (human), a fatty acid-derivatized analog of glucose-dependent insulinotropic polypeptide, exhibits enhanced antihyperglycemic and insulinotropic characteristics. This compound is utilize... | |||
T61414 | DPP-4 inhibitor 3 | ||
Compound 5a, also known as DPP-4 inhibitor 3, is a powerful dipeptidyl peptidase IV (DPP-IV) inhibitor, demonstrating an IC50 value of 0.75 nM. It exhibits outstanding antioxidant and insulinotropic activity [1]. | |||
T78543 | Acetyl Gastric Inhibitory Peptide (human) TFA | Human N-acetyl GIP TFA | |
Acetyl Gastric Inhibitory Peptide (human) TFA, a fatty acid-derivatized analog of the glucose-dependent insulinotropic polypeptide, exhibits enhanced antihyperglycemic and insulinotropic properties. It is utilized in the... | |||
T37601 | GIP (1-30) amide, porcine TFA | ||
GIP (1-30) amide, porcine TFA is a high-affinity full agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor, having a similar potency as the native GIP(1-42) [1]. Furthermore, GIP (1-30) amide, porci... | |||
T37589L | GIP (3-42), human acetate | GIP (3-42), human acetate(1802086-25-4 Free base) | IGF-1R |
GIP (3-42), human acetate is an antagonist of a glucose-dependent insulinotropic polypeptide (GIP) receptor and regulates insulin secretion and GIP metabolism in vivo. |